FDA NDC Directory · JSON-LD · Markdown

HYFTOR

NDC 73683-101 · HUMAN PRESCRIPTION DRUG · GEL

Generic namesirolimus
Labeler / ManufacturerNobelpharma America, LLC
Marketing categoryNew Drug Application (innovator) · App NDA213478
Dosage form / routeGEL · TOPICAL
Active ingredientsSIROLIMUS (2 mg/g)
Marketing started20220323
Package count1

External sources

Source: openFDA. Public-domain (CC0).